Nelsons uses modern production methods and rigorous quality control procedures to produce natural remedies that continue to uphold traditional values.
Our commitment to quality is supported by our company ethos:
We aim to make the highest quality natural healthcare products as widely available as possible.
We are committed to playing our part in delivering a stronger and more appropriate evidence base for the safety and efficacy of complementary medicines.
We support informed and appropriate regulation of complementary medicines to ensure safety and public confidence.
We are passionate advocates of an integrated approach to healthcare.
All of our employees play a fundamental role in the growth of the business. We work to ensure that each person understands the contribution they have to make and that everyone has the opportunity to share in the company's success. We strive to recruit and retain the best and we invest to allow our employees to develop their skills, grow as individuals and in teams and work in a safe and professional environment.
Owners of Nelsons since 1972, the Wilson family is passionately committed to complementary medicines and to supporting a wide range of charitable initiatives in the sector.
Our values are built on four pillars:
Quality & Regulation
Our range of products meet the appropriate UK and global regulatory and licensing requirements. They are made in our Wimbledon manufacturing facility which operates to Good Manufacturing Practice (GMP) and rigorous procedures.
Our traditional heritage is not lost and we still continue to prepare our homeopathic remedies to traditional Hahnemannian methods. Similarly, decades after Dr. Bach's death, his guiding principle of 'simplicity and purity in the method' remains paramount for all of us involved in the preparation of BACH® ORIGINAL FLOWER REMEDIES.
Manufacturing Standards - Our Wimbledon facilities conform to Good Manufacturing Practice (GMP) guidelines as stipulated by the European Medicines Directive and in accord with the World Health Organization (WHO) guidance. GMP controls and manages the manufacturing process for pharmaceutical products, to ensure they are consistently produced and made to quality standards appropriate to their intended use. Strict quality control procedures are applied throughout all stages of the manufacturing process to each batch of product made. Each batch is assigned a unique identification code or lot number. Every product released for sale can therefore be traced back to the manufacturing facility, the batch in which it was made, date of production, and even trace the exact raw materials used.
Pharmacovigilance - We continually monitor the safety of all our products manufactured through our Pharmacovigilance (surveillance of product safety) procedures. We assess all report relating to all our products and monitor both general and specialized information on the safety of natural products ingredients.
Manufacturing Authorization - Our manufacturing facilities are inspected regularly by the UK Medicines Inspectorate from the Medicines & Healthcare Products Regulatory Agency (MHRA), to ensure compliance with the European Directives 91/356/EEC and 2001/83/EEC, for Medicinal Products for Human Use.
Nelsons is committed to playing our part in developing and strengthening the evidence base for the safety and efficacy of complementary medicines. An essential element of our approach is to ensure that the nature of the evidence, and the methods used to collect it, are appropriate to the therapeutic approach.
Natural medicines exist in many forms, which have been used by mankind since long before the invention of western medicine and synthesized pharmaceutical products. Complementary medicines used today have generally thrived and survived because they have an excellent record of safety and successful use.
There is substantial anecdotal evidence and confidence in long-term use of complementary medicines. Recent World Health Organization figures reveal that more than 80% of the world's population use such medicines for their healthcare needs. In our own society, increasing numbers of people choose complementary medicines and therapies for use alongside conventional treatments to deliver positive outcomes.
Complementary medicine adopts a holistic approach to patient care, placing the individual at the heart of the treatment, rather than the symptoms.
Mainstream medicine seeks to develop and provide novel drugs that are effective and safe, and address symptoms and causes. Clinical trials, including the 'gold standard' double blind placebo controlled trial, have been developed to test how pharmaceuticals treat physical symptoms. They act as a measure of efficacy and safety — the evidence base that is required to achieve a license for a new product.
However recent definition of the human genome and the development of techniques that reveal a patient's specific DNA may lead to modern medicines being tailored to individual patients, not simply their symptoms — an approach that mimics complementary medicine's holistic philosophy. In this context, the double blind placebo controlled trial, held up as the 'holy grail' of evidence-based medicine may lose its hallowed status. Designed to test how pharmaceuticals treat physical symptoms not individuals, it cannot be the whole 'test' of complementary medicine. Audit trails that track outcomes of treatments and procedures and impact on quality of life for patients are now considered legitimate additions to dossiers of evidence, as are patient and professional testimonials.
An integrated approach to healthcare draws on complementary and alternative treatments as well as mainstream pharmacological medicines, providing a wider choice of effective healthcare options for consumers.
Global research together with rising sales figures for complementary medicines demonstrate that consumers are increasingly opting for an integrated approach to their own healthcare, drawing together complementary therapies and orthodox medical treatments. Complementary and alternative medicines have been shown to be cost-effective and often comparing favorably with mainstream products.
Throughout the world, publicly-funded Health Services, as well as private providers, are delivering and funding treatments such as osteopathy, homeopathy and hypnotherapy in hospitals and community practices on a routine basis.
We at Nelsons are committed to widening patient choice by developing and distributing complementary medicines, supported by appropriate information and educational resources for practitioners and patients alike.